Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.32 - $1.1 $208,896 - $718,080
652,800 Added 3313.71%
672,500 $578,000
Q2 2024

Aug 15, 2024

BUY
$0.36 - $0.65 $7,092 - $12,805
19,700 New
19,700 $7,000
Q4 2022

Feb 14, 2023

SELL
$2.77 - $5.07 $316,334 - $578,994
-114,200 Reduced 81.17%
26,500 $83,000
Q3 2022

Nov 14, 2022

BUY
$4.27 - $6.39 $31,170 - $46,647
7,300 Added 5.47%
140,700 $689,000

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $321M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.